NEW
YORK, Oct. 12, 2022 /PRNewswire/ -- The Gross
Law Firm issues the following notice to shareholders of
Medtronic plc.
Shareholders who purchased shares of MDT during the class period
listed are encouraged to contact the firm regarding possible lead
plaintiff appointment. Appointment as lead plaintiff is not
required to partake in any recovery.
CONTACT US HERE:
https://securitiesclasslaw.com/securities/medtronic-plc-loss-submission-form/?id=32503&from=4
CLASS PERIOD: This lawsuit is on behalf of persons and
entities who purchased or otherwise acquired Medtronic common stock
between June 8, 2019, and
May 25, 2022, inclusive.
ALLEGATIONS: The complaint alleges that during the class
period, Defendants issued materially false and/or misleading
statements and/or failed to disclose that: (1) Medtronic's product
quality control systems were inadequate; (2) Medtronic had failed
to comply with numerous regulations regarding risk assessment,
corrective and preventive action, complaint handling, device
recalls, and reporting of adverse events; (3) these failures
increased the risk of regulatory investigation and action; (4) as a
result of the Company's misconduct, the U.S. Food and Drug
Administration would delay the approval of additional Medtronic
MiniMed devices, including the MiniMed 780G; (5) these delays in
product approvals, as well as the Company's need to improve its
quality control systems, would negatively affect the Company's
financial performance and cause Medtronic to fall further behind
its competitors; and (6) as a result of the foregoing, defendants'
statements about the Company's business, operations, and prospects
lacked a reasonable basis.
DEADLINE: November 7, 2022
Shareholders should not delay in registering for this class action.
Register your information here:
https://securitiesclasslaw.com/securities/medtronic-plc-loss-submission-form/?id=32503&from=4
NEXT STEPS FOR SHAREHOLDERS: Once you register as a
shareholder who purchased shares of MDT during the timeframe listed
above, you will be enrolled in a portfolio monitoring software to
provide you with status updates throughout the lifecycle of the
case. The deadline to seek to be a lead plaintiff is November 7, 2022. There is no cost or obligation
to you to participate in this case.
WHY GROSS LAW FIRM? The Gross Law Firm is nationally
recognized class action law firm, and our mission is to protect the
rights of all investors who have suffered as a result of deceit,
fraud, and illegal business practices. The Gross Law Firm is
committed to ensuring that companies adhere to responsible business
practices and engage in good corporate citizenship. The firm seeks
recovery on behalf of investors who incurred losses when false
and/or misleading statements or the omission of material
information by a company lead to artificial inflation of the
company's stock. Attorney advertising. Prior results do not
guarantee similar outcomes.
CONTACT:
The Gross Law Firm
15 West 38th Street, 12th floor
New York, NY, 10018
Email: dg@securitiesclasslaw.com
Phone: (646) 453-8903
View original
content:https://www.prnewswire.com/news-releases/shareholder-alert-the-gross-law-firm-notifies-shareholders-of-medtronic-plc-of-a-class-action-lawsuit-and-a-lead-plaintiff-deadline-of-november-7-2022--nyse-mdt-301644389.html
SOURCE The Gross Law Firm